ZA773259B - Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects - Google Patents

Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects

Info

Publication number
ZA773259B
ZA773259B ZA00773259A ZA773259A ZA773259B ZA 773259 B ZA773259 B ZA 773259B ZA 00773259 A ZA00773259 A ZA 00773259A ZA 773259 A ZA773259 A ZA 773259A ZA 773259 B ZA773259 B ZA 773259B
Authority
ZA
South Africa
Prior art keywords
doses
relating
maintaining
reducing
methods
Prior art date
Application number
ZA00773259A
Other languages
English (en)
Inventor
K Blixt
R Juhlin
M Tiru
Original Assignee
Kockums Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kockums Chem filed Critical Kockums Chem
Publication of ZA773259B publication Critical patent/ZA773259B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/046Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a non-organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/651The particulate/core comprising inorganic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA00773259A 1976-06-29 1977-05-30 Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects ZA773259B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (sv) 1976-06-29 1976-06-29 Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans

Publications (1)

Publication Number Publication Date
ZA773259B true ZA773259B (en) 1978-04-26

Family

ID=20328328

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00773259A ZA773259B (en) 1976-06-29 1977-05-30 Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects

Country Status (24)

Country Link
JP (1) JPS533512A (fi)
AR (1) AR221686A1 (fi)
AU (1) AU2611177A (fi)
BE (1) BE848892A (fi)
CA (1) CA1080500A (fi)
DD (1) DD130984A5 (fi)
DE (1) DE2652163A1 (fi)
DK (1) DK518476A (fi)
ES (1) ES460159A1 (fi)
FI (1) FI61637C (fi)
FR (1) FR2356430A1 (fi)
GB (1) GB1572718A (fi)
GR (1) GR63669B (fi)
IL (1) IL52243A (fi)
IN (1) IN145766B (fi)
IT (1) IT1064524B (fi)
LU (1) LU76238A1 (fi)
MC (1) MC1116A1 (fi)
NL (1) NL7613404A (fi)
NO (1) NO146974C (fi)
PL (1) PL199237A1 (fi)
PT (1) PT66663B (fi)
SE (1) SE421042B (fi)
ZA (1) ZA773259B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026093B2 (ja) * 1978-03-14 1985-06-21 住友製薬株式会社 ゲフアルナート含有固型製剤の製造方法
IT1103817B (it) * 1978-06-27 1985-10-14 Guaber Spa Composizione deodorante granulare per posacenere
BE886778A (fr) * 1979-12-21 1981-06-19 Glaxo Group Ltd Melanges de cephalexine et de bioxyde de silicium a introduire dans des gelules pharmaceutiques
DK204682A (da) * 1981-05-08 1982-11-09 Wellcome Found Parfumeafgivende materiale
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU191245B (en) * 1984-01-06 1987-01-28 Egis Gyogyszergyar,Hu Process for the production of stbale pharmaceutical preparation against ketosis
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
EP0215136B1 (de) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin 1,3-Bis-(2-ethylhexyl)-hexahydro-5-methyl-5-pyrimidinamin enthaltendes therapeutisch wirkendes Mittel, sowie Verfahren zum Herstellen desselben und Verwendung als vaginales Desinfektionsmittel
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
DE19506141A1 (de) 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
EP0923312A1 (en) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Oral delivery form having a high absorption efficiency and method for making same
SG71877A1 (en) * 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
EP1104290B1 (en) * 1998-08-13 2010-03-31 Cima Labs Inc. Microemulsions as solid dosage forms for oral administration
CN102481257B (zh) * 2009-04-24 2014-08-13 Omya国际股份公司 用于控释活性成分的颗粒材料
WO2014078435A1 (en) 2012-11-14 2014-05-22 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5235736B2 (fi) * 1972-09-27 1977-09-10

Also Published As

Publication number Publication date
AU2611177A (en) 1978-12-21
FR2356430B1 (fi) 1982-08-13
DK518476A (da) 1977-12-30
IL52243A0 (en) 1977-08-31
LU76238A1 (fi) 1977-05-23
IT1064524B (it) 1985-02-18
FI61637B (fi) 1982-05-31
IL52243A (en) 1980-10-26
GR63669B (en) 1979-11-28
GB1572718A (en) 1980-07-30
PT66663B (en) 1978-11-13
PT66663A (en) 1977-07-01
NL7613404A (nl) 1978-01-02
SE421042B (sv) 1981-11-23
NO763947L (no) 1977-12-30
IN145766B (fi) 1978-12-16
FI763304A (fi) 1977-12-30
CA1080500A (en) 1980-07-01
PL199237A1 (pl) 1979-07-02
FI61637C (fi) 1982-09-10
NO146974C (no) 1983-01-26
DE2652163A1 (de) 1978-01-12
JPS533512A (en) 1978-01-13
BE848892A (fr) 1977-03-16
AR221686A1 (es) 1981-03-13
DD130984A5 (de) 1978-05-24
MC1116A1 (fr) 1977-08-12
ES460159A1 (es) 1978-10-01
FR2356430A1 (fr) 1978-01-27
NO146974B (no) 1982-10-04
SE7607389L (sv) 1977-12-30

Similar Documents

Publication Publication Date Title
PT67861A (en) Improvements in the process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing same
ZA761627B (en) Improvements in or relating to the treatment of arthritis
ZA753866B (en) Improvements in or relating to immobilization of biologically active substances
JPS5216295A (en) Controlling liquid for gases contained in blood
GB1542980A (en) Process for the preparation of low molecular weight polyhydroxyl compounds and their use in the preparation of polyurethanes
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
IL53584A (en) Biologically active protein or protein substrate bound on to ployamide and proces for producing the same
YU76184A (en) Process for obtaining plasters for controlled active substances emission to skin
IL57596A (en) Process for the purification and concentration of urokinase
DE2960499D1 (en) Process for the preparation of bi- and/or polyuret-polyisocyanates; products obtained by this process and their use in the preparation of polyurethanes
JPS5328133A (en) Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these
ZM5975A1 (en) Improvements in or relating to biological materials
DE2967324D1 (en) Pyrrolidine derivatives for use as therapeutically active substances and medicaments containing them
JPS52125613A (en) Biologically active composition
PT66160B (en) Improvements in or relating to the treatment of glass
JPS5522692A (en) Stable liquid drug composition and its manufacture
JPS554367A (en) Composition for reducing blood lipid concentration
DE3066533D1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions
JPS5678599A (en) Analysis of substance concentration in solution
JPS51139635A (en) Acting substance for beauty culture
JPS5522693A (en) Stable liquid drug composition and its manufacture
ZA775472B (en) Biologically active tetracyclic compounds and pharmaceutical compositions containing same
JPS5611795A (en) Biologically active substance
JPS52119993A (en) Electropheresis apparatus for liquid as blood and the like
JPS5362654A (en) Artificial cultivation and its container for fungus